Field Trip Health Ltd.
FTRP · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|
| Revenue | $5 | $1 | $0 |
| % Growth | 405.8% | 95,989.5% | – |
| Cost of Goods Sold | $9 | $2 | $0 |
| Gross Profit | -$4 | -$1 | -$0 |
| % Margin | -88.3% | -60.7% | -840.3% |
| R&D Expenses | $7 | $3 | $0 |
| G&A Expenses | $34 | $12 | $3 |
| SG&A Expenses | $38 | $14 | $3 |
| Sales & Mktg Exp. | $3 | $2 | $0 |
| Other Operating Expenses | $4 | $1 | $0 |
| Operating Expenses | $49 | $18 | $3 |
| Operating Income | -$54 | -$19 | -$3 |
| % Margin | -1,102.8% | -1,980.3% | -327,500% |
| Other Income/Exp. Net | -$1 | -$4 | $1 |
| Pre-Tax Income | -$55 | -$23 | -$3 |
| Tax Expense | $1 | $0 | $0 |
| Net Income | -$56 | -$23 | -$3 |
| % Margin | -1,147.9% | -2,405.9% | -262,800% |
| EPS | -8.44 | -3.5 | -0.35 |
| % Growth | -141.1% | -900% | – |
| EPS Diluted | -8.44 | -3.5 | -0.35 |
| Weighted Avg Shares Out | 7 | 7 | 8 |
| Weighted Avg Shares Out Dil | 7 | 7 | 8 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 |
| Depreciation & Amortization | $4 | $1 | $0 |
| EBITDA | -$50 | -$21 | -$2 |
| % Margin | -1,028.6% | -2,229.2% | -245,900% |